“Protective Effects of Swertia chirayata Extract Against Doxorubicin Induced Hepatotoxicity: Molecular Insights and Translational Implications”

Authors

  • Sulakshana Pal Singh , Lokesh Verma Author

DOI:

https://doi.org/10.48047/82ntsh13

Keywords:

Doxorubicin, hepatotoxicity, Swertia chirayata, oxidative stress, apoptosis, inflammation.

Abstract

Doxorubicin (DOX) is a widely used chemotherapeutic agent associated with severe hepatotoxicity due to oxidative stress, inflammation, and apoptosis. The present study evaluates the hepatoprotective effects of Swertia chirayata extract against DOX-induced liver toxicity in Wistar albino rats. Rats were divided into four groups: Control, DOX-only, Swertia chirayata 
(200 mg/kg), and Swertia chirayata (400 mg/kg). The study assessed biochemical parameters (ALT, AST, ALP, bilirubin), oxidative stress markers (MDA, SOD, GSH), and histopathological changes. 

Downloads

Download data is not yet available.

References

Aviles, A., et al. Doxorubicin-induced hepatotoxicity: An overview. Cancer Chemother Pharmacol. 1984;12(2):87-90.

Bains, S., et al. Cytochrome P450 and carbonyl reductases in doxorubicin metabolism. Drug Metab Rev. 2010;42(3):394-407.

Downloads

Published

2025-02-03

How to Cite

“Protective Effects of Swertia chirayata Extract Against Doxorubicin Induced Hepatotoxicity: Molecular Insights and Translational Implications” (Sulakshana Pal Singh , Lokesh Verma , Trans.). (2025). Cuestiones De Fisioterapia, 54(3), 1516-1540. https://doi.org/10.48047/82ntsh13